Medeon Biodesign (6499)

Currency in TWD
103.50
-3.50(-3.27%)
Closed·
6499 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6499 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
103.50112.50
52 wk Range
34.75154.50
Key Statistics
Bid/Ask
49.90 / 50.20
Prev. Close
48.7
Open
106
Day's Range
103.5-112.5
52 wk Range
34.75-154.5
Volume
2.48M
Average Volume (3m)
3.37M
1-Year Change
160.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6499 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
145.00
Upside
+40.10%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Medeon Biodesign Company Profile

Medeon Biodesign, Inc. researches, develops, manufactures, and sells medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is involved in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. The company was incorporated in 2012 and is based in Taipei, Taiwan.

Compare 6499 to Peers and Sector

Metrics to compare
6499
Peers
Sector
Relationship
P/E Ratio
−12.6x−206.8x−0.5x
PEG Ratio
−0.35−2.310.00
Price/Book
7.3x6.3x2.6x
Price / LTM Sales
28.4x10.0x3.3x
Upside (Analyst Target)
35.5%0.0%43.5%
Fair Value Upside
Unlock−14.7%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 145.00
(+40.10% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-1.93 / --
Revenue / Forecast
101.88M / --
EPS Revisions
Last 90 days

6499 Income Statement

FAQ

What Stock Exchange Does Medeon Biodesign Trade On?

Medeon Biodesign is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Medeon Biodesign?

The stock symbol for Medeon Biodesign is "6499."

What Is the Medeon Biodesign Market Cap?

As of today, Medeon Biodesign market cap is 9.86B.

What Is Medeon Biodesign's Earnings Per Share (TTM)?

The Medeon Biodesign EPS (TTM) is -8.50.

When Is the Next Medeon Biodesign Earnings Date?

Medeon Biodesign will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 6499 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medeon Biodesign Stock Split?

Medeon Biodesign has split 7 times.

How Many Employees Does Medeon Biodesign Have?

Medeon Biodesign has 39 employees.

What is the current trading status of Medeon Biodesign (6499)?

As of 07 Aug 2025, Medeon Biodesign (6499) is trading at a price of 103.50, with a previous close of 48.70. The stock has fluctuated within a day range of 103.50 to 112.50, while its 52-week range spans from 34.75 to 154.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.